Literature DB >> 28115796

Evaluation of rapid GeneXpert MTB/RIF method using DNA tissue specimens of vertebral bones in patients with suspected spondylitis TB.

Muhammad Nasrum Massi1, Karya Triko Biatko2, Irda Handayani3, Muhammad Yogi Pratama1, Sari Septriani4, Gaby Maulida Nurdin4, Marina B Ali4.   

Abstract

PURPOSE: To detect Mycobacterium tuberculosis DNA and rifampicin resistance in vertebral bone tissue specimens from spondylitis TB suspects. METHODS AND
RESULTS: The rapid GeneXpert MTB/RIF and MGIT 960 liquid culture methods have been used in the specimens. Results from 70 suspects with spondylitis TB shown that 31.42% identified positive for spondylitis TB using culture method, while 88.57% shown positive results using rapid GeneXpert MTB/RIF method. The validity of GeneXpert MTB/RIF shown sensitivity value of 100%, specificity value of 16.6%, PPV of 35.48%, and NPV of 100%.
CONCLUSION: GeneXpert has a high sensitivity but low specificity value in this study.

Entities:  

Keywords:  DNA M. tuberculosis; GeneXpert MTB/RIF; Specimen pus; Spondylitis TB

Year:  2017        PMID: 28115796      PMCID: PMC5226853          DOI: 10.1016/j.jor.2016.12.003

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  18 in total

1.  Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis.

Authors:  V C C Cheng; W C Yam; I F N Hung; P C Y Woo; S K P Lau; B S F Tang; K Y Yuen
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

2.  Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.

Authors:  Kai Chang; Weiping Lu; Junji Wang; Kejun Zhang; Shuangrong Jia; Fake Li; Shaoli Deng; Ming Chen
Journal:  J Infect       Date:  2012-02-27       Impact factor: 6.072

3.  Evaluation of the analytical performance of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Elizabeth Story; Danica Helb; JoAnn Kop; Padmapriya Banada; Michelle R Owens; Soumitesh Chakravorty; Martin Jones; David Alland
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

4.  Early diagnosis of spinal tuberculosis by MRI.

Authors:  S S Desai
Journal:  J Bone Joint Surg Br       Date:  1994-11

5.  Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Catharina Boehme; Elvira Richter
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

6.  Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens.

Authors:  Sylvie Armand; Pascale Vanhuls; Guy Delcroix; René Courcol; Nadine Lemaître
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

7.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

Review 8.  Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome.

Authors:  E M Trecarichi; E Di Meco; V Mazzotta; M Fantoni
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-04       Impact factor: 3.507

9.  Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing.

Authors:  Siva Raja; Jesus Ching; Liqiang Xi; Steven J Hughes; Ronald Chang; Wendy Wong; William McMillan; William E Gooding; Kenneth S McCarty; Melissa Chestney; James D Luketich; Tony E Godfrey
Journal:  Clin Chem       Date:  2005-03-03       Impact factor: 8.327

10.  Discrimination of tuberculous spondylitis from pyogenic spondylitis on MRI.

Authors:  Na-Young Jung; Won-Hee Jee; Kee-Yong Ha; Chun-Kun Park; Jae-Young Byun
Journal:  AJR Am J Roentgenol       Date:  2004-06       Impact factor: 3.959

View more
  6 in total

1.  Whole Genome Sequencing of Mycobacterium tuberculosis Isolates From Extrapulmonary Sites.

Authors:  Kusum Sharma; Renu Verma; Jayshree Advani; Oishi Chatterjee; Hitendra S Solanki; Aman Sharma; Subhash Varma; Manish Modi; Pallab Ray; Kanchan K Mukherjee; Megha Sharma; Mandeed Singh Dhillion; Mrutyunjay Suar; Aditi Chatterjee; Akhilesh Pandey; Thottethodi Subrahmanya Keshava Prasad; Harsha Gowda
Journal:  OMICS       Date:  2017-07

2.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

Review 3.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

Review 4.  Diagnostic accuracy of Xpert MTB/RIF assay for musculoskeletal tuberculosis: a meta-analysis.

Authors:  Hai Wen; Pengzhi Li; Hong Ma; Guohua Lv
Journal:  Infect Drug Resist       Date:  2017-09-28       Impact factor: 4.003

5.  Diagnostic accuracy evaluation of the conventional and molecular tests for Spinal Tuberculosis in a cohort, head-to-head study.

Authors:  Guirong Wang; Weijie Dong; Tinglong Lan; Jun Fan; Kai Tang; Yuan Li; Guangxuan Yan; Guanglu Jiang; Yifeng Ma; Yuanyuan Shang; Shibing Qin; Hairong Huang
Journal:  Emerg Microbes Infect       Date:  2018-06-20       Impact factor: 7.163

6.  Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis: A meta-analysis.

Authors:  Yanqin Shen; Guocan Yu; Fangming Zhong; Xiaohua Kong
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.